Implementation of multidisciplinary care reduces maternal mortality in women with sickle cell disease living in low-resource setting

American Journal of Hematology

Volumn 92, Issue 9, 2017, Pages 872-878

  Asare, Eugenia Vicky ^a,b   Olayemi, Edeghonghon ^a,b   Boafor, Theodore ^c   Dei Adomakoh, Yvonne ^b   Mensah, Enoch ^b   Ghansah, Harriet ^b   Osei Bonsu, Yvonne ^a   Crabbe, Selina ^a   Musah, Latif ^b   Hayfron Benjamin, Charles ^b,c   Covert, Brittany ^d   Kassim, Adetola A ^d   James, Andra ^e   Rodeghier, Mark ^f   DeBaun, Michael R ^d   Oppong, Samuel A ^b,c  

^a Ghana Institute of Clinical Genetics   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c KORLE BU TEACHING HOSPITAL   (Ghana)

^d MEHARRY MEDICAL COLLEGE   (United States)

^e DUKE UNIVERSITY   (United States)

^f Statistical Consultant   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CHEST SYNDROME; ADULT; AGE; ARTICLE; CASE FATALITY RATE; CAUSE OF DEATH; CESAREAN SECTION; FEMALE; FOLLOW UP; GHANA; HOSPITAL POLICY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL CARE; MATERNAL MORTALITY; PAIN; PARITY; PERINATAL MORTALITY; PREECLAMPSIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SICKLE CELL ANEMIA; SPONTANEOUS ABORTION; VAGINAL DELIVERY; ADOLESCENT; CLINICAL TRIAL; MORTALITY; MULTICENTER STUDY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDY;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL MORTALITY; PERINATAL MORTALITY; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 85020405508     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24790     Document Type: Article

References (21)

1. Organization WH. Management of Haemoglobin Disorders. Report of a Joint WHO-TIF Meeting. Nicosia, Cyprus; 2007.
2. Chaturvedi S, DeBaun MR. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years. Am J Hematol. 2016;91:5–14.
3. Le PQ, Gulbis B, Dedeken L, et al. Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatr Blood Cancer. 2015;62:1956–1961.
4. Oteng-Ntim E, Ayensah B, Knight M, et al. Pregnancy outcome in patients with sickle cell disease in the UK–a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease. Br J Haematol. 2015;169:129–137.
5. Dare FO, Makinde OO, Faasuba OB. The obstetric performance of sickle cell disease patients and homozygous hemoglobin C disease patients in Ile-Ife, Nigeria. Int J Gynaecol Obstet. 1992;37:163–168.
6. Odum CU, Anorlu RI, Dim SI, et al. Pregnancy outcome in HbSS-sickle cell disease in Lagos, Nigeria. West Afr J Med. 2002;21:19–23.
7. Wilson NO, Ceesay FK, Hibbert JM, et al. Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study. Am J Trop Med Hyg. 2012;86:936–942.
8. Muganyizi PS, Kidanto H. Sickle cell disease in pregnancy: trend and pregnancy outcomes at a tertiary hospital in Tanzania. PLoS One. 2013;8:e56541
9. Boafor TK, Olayemi E, Galadanci N, et al. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis. Bjog. 2016;123:691–698.
10. Bellet PS, Kalinyak KA, Shukla R, et al. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med. 1995;333:699–703.
11. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
12. Lucky L, Mulumba LW. Sickle cell disease among children in Africa: An integrative literature review and global recommendations. Int J Afr Nurs Sci. 2015;3:56–64.
13. McGann PT, Hernandez AG, Ware RE. Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. Blood. 2017;129:155–161.
14. Moulding NT, Silagy CA, Weller DP. A framework for effective management of change in clinical practice: dissemination and implementation of clinical practice guidelines. Qual Health Care. 1999;8:177–183.
15. Rahimy MC, Gangbo A, Adjou R, et al. Effect of active prenatal management on pregnancy outcome in sickle cell disease in an African setting. Blood. 2000;96:1685–1689.
16. Malinowski AK, Shehata N, D'souza R, et al. Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis. Blood. 2015;126:2424–2435. quiz 2437.
17. Ngo C, Kayem G, Habibi A, et al. Pregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusions. Eur J Obstet Gynecol Reprod Biol. 2010;152:138–142.
18. Smith JA, Espeland M, Bellevue R, et al. Pregnancy in sickle cell disease: experience of the Cooperative Study of Sickle Cell Disease. Obstet Gynecol. 1996;87:199–204.
19. Gynaecology DoOa. Annual Morbidity and Mortality Report 2014. Accra, Ghana: Korle-Bu Teaching Hospital; 2014.
20. WHO U, UNFPA, World Bank Group and the United Nations Population Division. Trends in Maternal Mortality: 1990 to 2015. 2015. pp 1–77.
21. MacDorman MF, Gregory EC. Fetal and perinatal mortality: United States, 2013. Natl Vital Stat Rep. 2015;64:1–24.